Public Profile

DURECT Corporation

DURECT Corporation, a leading biopharmaceutical company based in the United States, focuses on developing innovative therapeutics for chronic diseases and pain management. Founded in 1998, DURECT has made significant strides in the industry, particularly with its proprietary drug delivery technologies and formulations. Headquartered in Cupertino, California, the company operates primarily in the biopharmaceutical sector, specialising in long-acting injectable products and novel drug delivery systems. DURECT's core offerings, such as its DUR-928 and the SABER® technology platform, stand out for their potential to enhance patient outcomes through improved efficacy and reduced side effects. With a strong market position, DURECT has garnered attention for its commitment to advancing healthcare solutions, making it a notable player in the biopharmaceutical landscape.

DitchCarbon Score

How does DURECT Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

DURECT Corporation's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

DURECT Corporation's reported carbon emissions

DURECT Corporation, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data may indicate that the company is in the early stages of developing its sustainability strategy or reporting framework. As the industry increasingly prioritises climate action, DURECT Corporation may consider establishing measurable targets and initiatives to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DURECT Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DURECT Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DURECT Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Talphera, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Cumberland Pharmaceuticals Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Zyla Life Sciences

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Zevra Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Supernus Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers